ribociclib

It May Be Time For Standard Breast Cancer Treatment To Change
Forbes
Sun, 10/6/19 - 12:44 pm
breast cancer
HER2-negative breast cancer
Novartis
ribociclib
Watch out Pfizer, Novartis’ LEE011 bags quick OK for frontline use against breast cancer
Endpoints
Tue, 03/14/17 - 09:38 am
Pfizer
Novartis
LEE011
Ibrance
ribociclib
Kisqali
breast cancer
Pfizer wins EU's approval for Ibrance as Novartis readies rival drug
Yahoo/Reuters
Thu, 11/10/16 - 11:21 am
Pfizer
Europe
Ibrance
breast cancer
Novartis
ribociclib
Novartis Takes Aim at Pfizer
Motley Fool
Thu, 11/3/16 - 09:48 am
Novartis
Pfizer
breast cancer
ribociclib
Ibrance
Novartis Targets Breast Cancer Drug Approval to Take on Pfizer
Bloomberg
Sat, 10/8/16 - 03:48 pm
Novartis
Pfizer
breast cancer
ribociclib